Low-density lipoprotein receptor-related protein polymorphisms in patients with elevated factor VIII coagulant activity and venous thrombosis

Blood Coagulation and Fibrinolysis

Volumn 16, Issue 7, 2005, Pages 465-468

  Cunningham, Nicholas ^a   Laffan, Michael A ^a   Manning, Richard A ^a   O'Donnell, James S ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Factor VIII; Low density lipoprotein receptor related protein; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 8; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EXON; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN POLYMORPHISM; RISK FACTOR; VENOUS THROMBOEMBOLISM;

EID: 29144495242     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000178831.45049.aa     Document Type: Article

References (22)

1. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345:152-155.
2. O'Donnell J, Tuddenham EG, Manning R, Kemball-Cook G, Johnson D, Laffan M. High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost 1997; 77:825-828.
3. Kraaijenhagen RA, in't Anker PS, Koopman MM, Reitsma PH, Prins MH, van den Ende A, et al. High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000; 83:5-9.
4. O'Donnell J, Mumford AD, Manning RA, Laffan M. Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response. Thromb Haemost 2000; 83:10-13.
5. Kyrle PA, Minar E, Hirschl M, Bialonczyk C, Stain M, Schneider B, et al. High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000; 343:457-462.
6. Kamphuisen PW, Houwing-Duistermaat JJ, van Houwelingen HC, Eikenboom JC, Bertina RM, Rosendaal FR. Familial clustering of factor VIII and von Willebrand factor levels. Thromb Haemost 1998; 79:323-327.
7. Strickland DK, Kounnas MZ, Argraves WS. LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. FASEB J 1995; 9:890-898.
8. Lenting PJ, Neels JG, van den Berg BM, Clijsters PP, Meijerman DW, Pannekoek H, et al. The light chain of factor VIII comprises a binding site for low density lipoprotein receptor-related protein. J Biol Chem 1999; 274:23734-23739.
9. Saenko EL, Yakhyaev AV, Mikhailenko I, Strickland DK, Sarafanov AG. Role of the low density lipoprotein-related protein receptor in mediation of factor VIII catabolism. J Biol Chem 1999; 274:37685-37692.
10. Bovenschen N, Herz J, Grimbergen JM, Lenting PJ, Havekes LM, Mertens K, et al. Elevated plasma factor VIII in a mouse model of low-density lipoprotein receptor-related protein deficiency. Blood 2003; 101:3933-3939.
11. Van Leuven F, Stas L, Thiry E, Nelissen B, Miyake Y. Strategy to sequence the 89 exons of the human LRP1 gene coding for the lipoprotein receptor related protein: identification of one expressed mutation among 48 polymorphisms. Genomics 1998; 52:138-144.
12. Hollenbach E, Ackermann S, Hyman BT, Rebeck GW. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 1998; 50:1905-1907.
13. Kang DE, Saitoh T, Chen X, Xia Y, Masliah E, Hansen LA, et al. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 1997; 49:56-61.
14. Lambert JC, Wavrant-De Vrieze F, Amouyel P, Amouyel P, Chartier-Harlin MC. Association at LRP gene locus with sporadic late-onset Alzheimer's disease. Lancet 1998; 351:1787-1788.
15. Morange PE, Tregouet DA, Frere C, Saut N, Pellegrina L, Alessi MC, et al. Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Br J Haematol 2005; 128:91-99.
16. Van Leuven F, Thiry E, Stas L, Nelissen B. Analysis of the human LRPAP1 gene coding for the lipoprotein receptor-associated protein: identification of 22 polymorphisms and one mutation. Genomics 1998; 52:145-151.
17. Gonzalez P, Alvarez R, Reguero JR, Batalla A, Alvarez V, Cortina A, et al. Variation in the lipoprotein recetor-related protein, alpha2-macroglobulin and lipoprotein receptor-associated genes in relation to plasma lipid levels and risk of early myocardial infarction. Coron Artery Dis 2002; 13:251-254.
18. McIlroy SP, Dynan KB, Vahidassr DJ, Lawson JT, Patterson CC, Passmore P. Common polymorphisms in LRP and A2M do not affect genetic risk for Alzheimer disease in Northern Ireland. Am J Med Genet 2001; 105:502-506.
19. Mansvelt EP, Laffan M, McVey JH, Tuddenham EG. Analysis of the F8 gene in individuals with high plasma factor VIII: C levels and associated venous thrombosis. Thromb Haemost 1998; 80:561-565.
20. Roelse JC, Koopman MM, Buller HR, ten Cate JW, Montaruli B, van Mourik JA, et al. Absence of mutations at the activated protein C cleavage sites of factor VIII in 1 25 patients with venous thrombosis. Br J Haematol 1996; 92:740-743.
21. Bowen DJ, MacLean RM, Pellard S, Collins PW. High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated? Br J Haematol 2001; 113:655-657.
22. Sanchez-Guerra M, Combarros O, Infante J, Llorca J, Berciano J, Fontalba A, et al. Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease. Neurosci Lett 2001; 316:17-20.